102 On the other hand, numerous teams are advocating for the incorporation of novel markers, like a elaborate karyotype55 or epigenetic subsets, 27,28 into clinical apply. All of these novel prognostic and/or predictive products will have to be validated in cohorts of sufferers addressed with targeted agents.This methylation profile is currently ac